SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chiron

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: vinod Khurana who wrote (12)5/17/1996 2:55:00 PM
From: vinod Khurana   of 23
 
Chiron may be worth keeping an eye on based on these technical facts:

1) The stock first broke (on the downside) the 200 day moving average
in late March. Since then, it has attempted a comeback at least twice (crossing the 200 MA by a few points). The third attempt seems to be on the horizon. Each time the attempt is made, the stock passes the $100 level and then drops to the $90 - $95 level.

2) The drop to the $95 level represents just over a 20% drop since it
reached a high on Mar 6th, 1996 ($119 1/4). The news in the press has been generally neutral and the drop can not be explained by the company (see news articles on StockTalk).

3) There are June/July 125 call options trading on this stock indicating that the professionals expect it to trade in the $90 - $125 level over the coming weeks.

We should expect a rebound to the $110 level by July end if not sooner. I have taken a very small position (2 contracts) in the June 100 call options this morning at $4 1/8. I will add further once it is determined that the stock is on the uptrend.

I am not expecting the stock to go as high as $125 but one can expect a 50% increase in the value of the June 100 call options as the stock approaches $105.

Good luck in your investments(s).

V.K
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext